Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation

Barbara L. Andersen, Robert J. DeRubeis, Barry S. Berman, Jessie Gruman, Victoria Champion, Mary Jane Massie, Jimmie C. Holland, Ann H. Partridge, Kate Bak, Mark R. Somerfield, Julia H. Rowland

Research output: Contribution to journalReview article

237 Citations (Scopus)

Abstract

Purpose: A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation. Methods: American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability. Results On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series. Conclusion: Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer.

Original languageEnglish (US)
Pages (from-to)1605-1619
Number of pages15
JournalJournal of Clinical Oncology
Volume32
Issue number15
DOIs
StatePublished - May 20 2014

Fingerprint

Anxiety
Guidelines
Depression
Medical Oncology
Neoplasms
Practice Guidelines
Survival Rate
Quality of Life
Organizations
Morbidity
Costs and Cost Analysis
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer : An American Society of Clinical Oncology guideline adaptation. / Andersen, Barbara L.; DeRubeis, Robert J.; Berman, Barry S.; Gruman, Jessie; Champion, Victoria; Massie, Mary Jane; Holland, Jimmie C.; Partridge, Ann H.; Bak, Kate; Somerfield, Mark R.; Rowland, Julia H.

In: Journal of Clinical Oncology, Vol. 32, No. 15, 20.05.2014, p. 1605-1619.

Research output: Contribution to journalReview article

Andersen, BL, DeRubeis, RJ, Berman, BS, Gruman, J, Champion, V, Massie, MJ, Holland, JC, Partridge, AH, Bak, K, Somerfield, MR & Rowland, JH 2014, 'Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation', Journal of Clinical Oncology, vol. 32, no. 15, pp. 1605-1619. https://doi.org/10.1200/JCO.2013.52.4611
Andersen, Barbara L. ; DeRubeis, Robert J. ; Berman, Barry S. ; Gruman, Jessie ; Champion, Victoria ; Massie, Mary Jane ; Holland, Jimmie C. ; Partridge, Ann H. ; Bak, Kate ; Somerfield, Mark R. ; Rowland, Julia H. / Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer : An American Society of Clinical Oncology guideline adaptation. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 15. pp. 1605-1619.
@article{21f1dcd8bc4f49e09b6278a58423f1f0,
title = "Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation",
abstract = "Purpose: A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation. Methods: American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability. Results On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series. Conclusion: Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer.",
author = "Andersen, {Barbara L.} and DeRubeis, {Robert J.} and Berman, {Barry S.} and Jessie Gruman and Victoria Champion and Massie, {Mary Jane} and Holland, {Jimmie C.} and Partridge, {Ann H.} and Kate Bak and Somerfield, {Mark R.} and Rowland, {Julia H.}",
year = "2014",
month = "5",
day = "20",
doi = "10.1200/JCO.2013.52.4611",
language = "English (US)",
volume = "32",
pages = "1605--1619",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15",

}

TY - JOUR

T1 - Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer

T2 - An American Society of Clinical Oncology guideline adaptation

AU - Andersen, Barbara L.

AU - DeRubeis, Robert J.

AU - Berman, Barry S.

AU - Gruman, Jessie

AU - Champion, Victoria

AU - Massie, Mary Jane

AU - Holland, Jimmie C.

AU - Partridge, Ann H.

AU - Bak, Kate

AU - Somerfield, Mark R.

AU - Rowland, Julia H.

PY - 2014/5/20

Y1 - 2014/5/20

N2 - Purpose: A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation. Methods: American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability. Results On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series. Conclusion: Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer.

AB - Purpose: A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation. Methods: American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability. Results On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series. Conclusion: Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer.

UR - http://www.scopus.com/inward/record.url?scp=84903816776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903816776&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.52.4611

DO - 10.1200/JCO.2013.52.4611

M3 - Review article

C2 - 24733793

AN - SCOPUS:84903816776

VL - 32

SP - 1605

EP - 1619

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

ER -